Category: Workers Comp

499 posts found

NSAID Use and COVID-19

FDA investigates claims that NSAID use could aggravate COVID-19 symptoms.

COVID-19 drug trials are underway, but the pandemic is disrupting clinical testing.

Cause Code 83 for Pandemic and Nature Code 83 for COVID-19 will impact future reporting for claims impacted by coronavirus.

Healthesystems has created a developments webpage to track updates impacting workers’ comp.

Anjeso and a new Advil formulation target pain, while Nurtec™ and Vyepti™ target migraines.

Healthesystems collaborated with Risk & Insurance to survey 669 workers’ comp professionals on top trends and challenges.

A study of 41,000 adults finds that only treatment with buprenorphine or methadone reduced risk of overdose.

Several state workers’ comp programs are relaxing telehealth rules to promote social distancing.

Healthesystems’ AVP of Advocacy & Compliance discusses industry challenges, special initiatives, and more in a video spotlight.

A new seizure drug has been approved, and a nerve growth drug advances in clinical trials.

What will 2020 hold for marijuana acceptance, employee misclassification, formularies, and AI?

An analysis of 1.5 million claims found early physical therapy lowers odds of opioid use by 14%.

Testing positive for marijuana use could one day no longer prohibit employment.

With a flurry of opioid developments lately, what does the big picture look like?

Migraine, arthritis, and insomnia drug approvals, and a gabapentinoids safety warning.

Prev 1 2 3 4 5 … 23 24 25 26 27 … 30 31 32 33 34 Next